title: Effects of glutamate receptor agonists and antagonists on Ca2+ uptake in rat hippocampal slices lesioned by glucose deprivation or by kainate.
abstract: The functional relevance of presynaptic glutamate receptors in controlling presynaptic Ca2+ influx and thereby transmitter release is unknown. To test if presynaptic Ca2+ entry in the hippocampus is controlled by glutamate autoreceptors, we created a hippocampal slice preparation for investigation of presynaptic Ca2+ signals with Ca(2+)-sensitive microelectrodes after lesioning of neurons by glucose deprivation or kainate. Stratum radiatum and alveus stimulation-induced postsynaptic field potential components were irreversibly abolished in areas CA1 and CA3 of lesioned slices, whereas stratum radiatum stimulation still evoked afferent volleys. Repetitive stimulation of the stratum radiatum still induced decreases in extracellular Ca2+ concentration. Repetitive stimulation of the alveus no longer induced decreases in extracellular Ca2+ concentration, suggesting complete damage of pyramidal cells. The stratum radiatum stimulation-induced decreases in extracellular Ca2+ concentration in lesioned slices were comparable to those elicited during application of the glutamate antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and L-2-amino-5-phosphonovalerate. In lesioned slices the stimulus-induced presynaptic Ca2+ influx was reversibly reduced by kainate. RS-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), N-methyl-D-aspartate and glutamate without effects on afferent volleys. The kainate and N-methyl-D-aspartate effects on presynaptic Ca2+ signals were partly sensitive to 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)quinoxaline and L-2-amino-5-phosphonovalerate, respectively, while the AMPA effects were not significantly affected by 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)quinoxaline, suggesting involvement of a novel glutamate receptor subtype. The involvement of a novel glutamate receptor subtype was supported by our findings that ionotropic glutamate receptor agonists also reduce presynaptic Ca2+ influx under conditions of blocked synaptic transmission by 6-cyano-7-nitroquinoxaline-2,3-dione and L-2-amino-5-phosphonovalerate. 1-Aminocyclopentane-trans-1,3-dicarboxylic acid had no significant effect on presynaptic Ca2+ entry. Also, the presynaptic Ca2+ influx was not influenced by the glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione, 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)quinoxaline and L-2-amino-5-phosphonovalerate when applied alone. Low kainate concentrations (5 microM) reduced presynaptic Ca2+ signals in area CA3 but not in area CA1, demonstrating the higher affinity of presynaptic kainate receptors on mossy fibre terminals.
authors.affiliation: Department of Neurophysiology, Charité, Medical School, Humboldt University, Berlin, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Alici
authors.forename: T
authors.initials: T
authors.lastname: Gloveli
authors.forename: D
authors.initials: D
authors.lastname: Schmitz
authors.forename: U
authors.initials: U
authors.lastname: Heinemann
mesh_terms: D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000493:pharmacokinetics*; D003515:Cycloleucine / Q000031:analogs & derivatives / Q000494:pharmacology; D004594:Electrophysiology; D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D006624:Hippocampus / Q000737:chemistry / Q000502:physiology*; D007608:Kainic Acid; D008297:Male; D016202:N-Methylaspartate / Q000494:pharmacology; D018696:Neuroprotective Agents / Q000494:pharmacology; D009924:Organ Culture Techniques; D011810:Quinoxalines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D017470:Receptors, Glutamate / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / Q000494:pharmacology
chemical_list: D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists; D018696:Neuroprotective Agents; D011810:Quinoxalines; D017470:Receptors, Glutamate; D003515:Cycloleucine; C036361:1-amino-1,3-dicarboxycyclopentane; C062865:2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline; D016202:N-Methylaspartate; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; D005947:Glucose; D007608:Kainic Acid; D002118:Calcium